<\/span><\/h2>\n\n\n\nIn\nIndia, there is no explicit legislation that controls digital health. The\nfollowing laws are briefly examined since they widely cover digital healthcare\nsector:<\/p>\n\n\n\n
Drugs and Cosmetics Act 1940 read with Drugs and\nCosmetics Rules 1945 and Draft E-Pharmacy Rules, 2018<\/strong><\/p>\n\n\n\nThe\nprincipal regulatory framework that controls the manufacturing, sale, import,\nand distribution of medications in India is the Drugs and Cosmetics Act of 1940\n(DCA) read with the Drugs and Cosmetics Regulations Rules, 1945 (DCR). The DCA\nmust be enforced, and that responsibility falls on both the central and state\ngovernments. The Drug Controller General of India (DCGI) is in charge of the\nCentral Drugs Standard Control Organization (CDSCO), which is primarily in\ncharge of coordinating the activities of the State Drugs Control Organization,\ndeveloping policies, and ensuring that the DCA is implemented consistently\nacross India. State Licensing Authorities (SLA) are another entity that\noversees how the DCA is applied in various states.<\/p>\n\n\n\n
According\nto the DCR, prescription medications can only be provided upon presentation of\na valid prescription that complies with the guidelines. Rule 65(10)(a)<\/em> of the D&C Rules states that a prescription must\nbe in written, signed, and dated by the doctor writing it in order to be\nlegitimate.<\/p>\n\n\n\nIn\nresponse to the COVID-19 epidemic, the Health Ministry announced in March 2020\nthat doorstep medicine delivery was now permitted. Significantly, the\nNotification was issued in accordance with Section\n26B<\/em> of the D&C Act, which enables the Central Government to control the\nproduction, sale, and distribution of drugs when doing so is in the public\ninterest, such as during epidemics or other natural disasters.<\/p>\n\n\n\nThe National Medical Commission Act, 2019 and The\nIndian Medical Council (Professional conduct, Etiquette and Ethics)\nRegulations, 2002<\/strong><\/p>\n\n\n\nIn\nIndia, medical education and practice are governed by the National Medical Commission\nAct, 2019 (the NMC Act). According to the NMC Act, only those with a recognised\nmedical degree and who have completed the National Exit Exam are eligible to\nregister with the State or National Registers in order to get a licence to\npractise medicine in India.<\/p>\n\n\n\n
According\nto the Indian Medical Council (Professional conduct, etiquette and ethics)\nRules, 2002 (also known as the MCI Code), doctors must adhere to certain moral\nand professional standards while dealing with patients, pharmaceutical firms,\nand other medical professionals.<\/p>\n\n\n\n
Telemedicine Practice Guidelines, 2020<\/strong>\n<\/p>\n\n\n\nIn\ncollaboration with NITI Aayog, the Central Government released the Telemedicine\nPractice Guidelines, 2020 (Telemedicine Guidelines). These recommendations are\nnow part of the MCI Code and are consequently mandatory for allopathic medical\nprofessionals. Along with classifying medications into List O, List A, List B,\nand Banned Lists, the Telemedicine Guidelines also outline which medications\ncan be provided under what circumstances.<\/p>\n\n\n\n
The Drugs and Magic Remedies (Objectionable\nAdvertisements) Act, 1954 and Drugs and Magic Remedies (Objectionable\nAdvertisements) Rules, 1955 (DMRA) <\/strong><\/p>\n\n\n\nThe\nDMRA was passed in 1954 to prevent the promotion of medications and treatments\nthat were said to have magical properties. According to the DMRA, it is\nunlawful for anybody to participate in the publishing of an advertising for a\nmedication that suggests or is intended to encourage the use of the drug for:<\/p>\n\n\n\n
- The\nabolition of female conceiving or the facilitation of miscarriage;\nalternatively<\/li>
- The\npreservation or enhancement of a person’s ability for sexual enjoyment; or<\/li>
- The\ntreatment of women’s menstruation disorders; or<\/li>
- The\nidentification, treatment, mitigation, prevention, or cure of any illness,\nailment, or condition included in the DMRA schedule.<\/li><\/ol>\n\n\n\n
On\nFebruary 3, 2020, the Ministry of Health and Family Welfare released a draught\namendment to the DMRA with the goals of expanding the list of diseases,\ndisorders, and conditions in the schedule to the DMRA and changing the\ndefinition of “advertisement” under the DMRA to specifically include\nadvertisements made over an online or electronic medium.<\/p>\n\n\n\n
The Clinical Establishments (Registration and\nRegulation) Act of 2010 <\/strong><\/p>\n\n\n\nEstablishments\nthat meet the criteria for a \u2018clinical establishment\u2019 as defined by the\nClinical Establishments (Registration and Regulation) Act, 2010 (CE Act), must\nregister with the appropriate government and adhere to the act’s minimal\nrequirements. Except for the NCT of Delhi, all Union Territories, including\nArunachal Pradesh, Himachal Pradesh, Mizoram, Sikkim, Bihar, Rajasthan, Uttar\nPradesh, Uttarakhand, Jharkhand, Assam, and Haryana, are subject to the\nClinical Establishments Act. State clinical establishment laws exist in certain\nstates, including Maharashtra and Karnataka. <\/p>\n\n\n\n
Telecom Commercial Communication Customer Preference Regulations\nof 2018 (TCCP Regulations)<\/strong><\/p>\n\n\n\nThe\nTCCP Rules and TCCP Regulations forbid sending unsolicited commercial\ncommunications by phone or SMS. Only users who have chosen to receive such\ncommunications can get promotional messages after registering with an access\nprovider. Sending phone calls or transactional SMS is not prohibited by law,\nnevertheless. As long as the recipient is a client of the sender, the message is\ndelivered within 30 minutes of the transaction taking place, and it is directly\nconnected to it, a transactional communication is one that is triggered by a\ntransaction carried out by the message’s recipient.<\/p>\n\n\n\n
Consumer Protection Act and 2019 and Consumer Protection\n(E-commerce) Rules and 2020<\/strong><\/p>\n\n\n\nThe\nConsumer Protection Act, 2019 (CPA) establishes a redressal process and\nprotects consumers’ interests. It places several obligations on retailers and\nservice providers, such as the ban of deceptive advertising and the\nestablishment of a system of product responsibility. The Central Consumer\nProtection Authority (CCPA) is the CPA’s regulatory authority, which oversees\nCPA administration and imposes sanctions. In addition, a customer may directly\nregister complaints for CPA breaches through a three-tiered consumer dispute\nresolution process.<\/p>\n\n\n\n
The\nCPA has also released the Consumer Protection (E-commerce) Regulations, 2020\n(E-commerce Rules) to control online advertising, sales, and purchases of goods\nand services. The Legal Metrology Regulations, 2011, IT Act, and other relevant\nrules that apply to online sales of goods are also included in the E-Commerce\nRules.<\/p>\n\n\n\n